1/17
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Which type of phase studies:
Cause unacceptable adverse effects.
Are highly teratogenic.
Lack evidence of potential therapeutic effect in humans.
Phase I
Which type of phase studies:
Less effective than anticipated.
Too toxic when used patients.
Produces unacceptable adverse effects.
Low benefit-to-risk ratio.
No more effective than other drugs already on the market.
Phase II
Which type of phase studies:
Produce unacceptable side effects
Produce unexpected responses
Phase III
Which type of phase studies:
Some drugs cause unexpected effects that are not seen until wide distribution occurs.
Sometimes, those effects are therapeutic.
Phase IV
Which category of pregnancy drugs:
Adequate studies show no risk to fetus in the first trimester.
No evidence of risk in later trimesters.
Category A
Which category of pregnancy drugs:
Animal studies have not demonstrated a risk to the fetus.
No adequate studies in pregnant people, or animal studies have shown an adverse effect.
Adequate studies in pregnant people have not demonstrated a risk to the fetus during the first trimester of pregnancy.
There is no evidence of risk in later trimesters.
Category B
Which category of pregnancy drugs:
Animal studies have shown an adverse effect on the fetus.
There are no adequate studies in humans.
Benefits from the use of the drug in pregnant people may be acceptable despite its potential risks.
There are no animal reproduction studies and no adequate studies in humans.
Category C
Which category of pregnancy drugs:
There is evidence of human fetal risk.
Potential benefits from the use of the drug in pregnant people may be acceptable despite its potential risks.
Category D
Which category of pregnancy drugs:
Studies in animals or humans demonstrate fetal abnormalities or adverse reactions; reports indicate evidence of fetal risk.
Risk of use in a pregnant person clearly outweighs any possible benefit.
Category X
Which type of schedule of controlled substances:
High abuse potential and no accepted medical use.
Ex: heroin, lysergic acid diethylamide.
Schedule I (C-I)
Which type of schedule of controlled substances:
High abuse potential with severe dependence liability.
Ex: narcotics, amphetamines, and barbiturates.
Schedule II (C-II)
Which type of schedule of controlled substances:
Less abuse potential than schedule II drugs and moderate dependence liability.
Ex: nonbarbiturate sedatives, nonamphetamine stimulants, limited amounts of certain narcotics.
Schedule III (C-III)
Which type of schedule of controlled substances:
Less abuse potential than schedule III and limited dependence liability.
Ex: some sedatives, antianxiety agents, and nonnarcotic analgesics.
Schedule IV (C-IV)
Which type of schedule of controlled substances:
Limited abuse potential.
Primarily small amounts of narcotics (codeine) used as antitussives or antidiarrheals.
The purchaser must be at least 18 years of age and must furnish suitable identification.
All such transactions must be recorded by the dispensing pharmacist.
Schedule V (C-V)
Which drug type:
Are chemicals that are produced by companies involved solely in the manufacturing of drugs.
Must have the same strength of the active ingredient as brand name.
Must use the same dosage form (tablet, capsule, or liquid) as brand name.
Must have the same route of administration (oral, topical, or injectable) as brand name.
Generic Drugs
Which drug type:
Treat rare diseases or conditions but are not financially viable
Have not been “adopted” by any drug company.
Orphan Drugs
Which drug type:
Are products that are available without prescription for self-treatment of a variety of complaints.
Some of these agents were approved as prescription drugs but later were found to be very safe and useful for patients without the need of a prescription.
Some were not rigorously screened and tested.
Over-the-Counter (OTC) Drugs
Which drug type:
Do not require a prescription but have more restrictions than OTC medications.
Must be kept in a secure location in the store (such as in a locked cabinet or within the pharmacy).
Must be sold by pharmacy staff to the customer.
Behind-the-Counter (BTC) drugs